Cooper, Thomas B.
Nathan Kline Institute for Psychiatric Research · New York State Psychiatric Institute · Columbia University
28 papers on CoChatORCID 0000-0001-6048-3479
Most cited papers
- Verified
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology
Cannabis and Cannabinoid ResearchSchizophrenia research and treatment
Cited by 1,024
- Verified
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 1,020
- Verified
Continuation Pharmacotherapy in the Prevention of Relapse Following Electroconvulsive Therapy: A Randomized Controlled Trial
Sackeim, H. A., Haskett, R. F., Mulsant, B. H., Thase, M. E., Mann, J. J., Pettinati, H. M., Greenberg, R. M., Crowe, R. R., Cooper, T. B., & Prudic, J. (2001) · JAMA
Electroconvulsive Therapy StudiesTreatment of Major Depression
Cited by 686
- Verified
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry
Cannabis and Cannabinoid ResearchSchizophrenia research and treatment
Cited by 617
- Verified
Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography. Part II: Amphetamine-Induced Dopamine Release in the Functional Subdivisions of the Striatum
Martinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism
Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment
Cited by 569
- Verified
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M. (2010) · Archives of General Psychiatry
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 565
- Verified
Double-Blind and Placebo-Controlled Study of Lithium for Adolescent Bipolar Disorders With Secondary Substance Dependency
GELLER, B., COOPER, T. B., SUN, K., ZIMERMAN, B., FRAZIER, J., WILLIAMS, M., & HEATH, J. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry
Bipolar Disorder and TreatmentSchizophrenia research and treatment
Cited by 526
- Verified
Circadian Time of Morning Light Administration and Therapeutic Response in Winter Depression
Terman, J. S., Terman, M., Lo, E.-S., & Cooper, T. B. (2001) · Archives of General Psychiatry
Circadian rhythm and melatoninTreatment of Major Depression
Cited by 366
- Verified
Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine
Martinez, D., Narendran, R., Foltin, R. W., Slifstein, M., Hwang, D.-R., Broft, A., Huang, Y., Cooper, T. B., Fischman, M. W., Kleber, H. D., et al. (2007) · American Journal of Psychiatry
Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes
Cited by 351
- Verified
Comparative and Interactive Human Psychopharmacologic Effects of Ketamine and Amphetamine: Implications for Glutamatergic and Dopaminergic Model Psychoses and Cognitive Function
Krystal, J. H., Perry, E. B., Gueorguieva, R., Belger, A., Madonick, S. H., Abi-Dargham, A., Cooper, T. B., MacDougall, L., Abi-Saab, W., & D’Souza, D. C. (2005) · Archives of General Psychiatry
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 317
- Verified
Positron Emission Tomography of Regional Brain Metabolic Responses to a Serotonergic Challenge and Lethality of Suicide Attempts in Major Depression
Oquendo, M. A., Placidi, G. P. A., Malone, K. M., Campbell, C., Keilp, J., Brodsky, B., Kegeles, L. S., Cooper, T. B., Parsey, R. V., Van Heertum, R. L., et al. (2003) · Archives of General Psychiatry
Suicide and Self-Harm StudiesTreatment of Major Depression
Cited by 313
- Verified
Cocaine Dependence and D2 Receptor Availability in the Functional Subdivisions of the Striatum: Relationship with Cocaine-Seeking Behavior
Martinez, D., Broft, A., Foltin, R. W., Slifstein, M., Hwang, D.-R., Huang, Y., Perez, A., Frankel, W. G., Cooper, T., Kleber, H. D., et al. (2004) · Neuropsychopharmacology
Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes
Cited by 306
- Verified
Sudden Death and Use of Stimulant Medications in Youths
Gould, M. S., Walsh, B. T., Munfakh, J. L., Kleinman, M., Duan, N., Olfson, M., Greenhill, L., & Cooper, T. (2009) · American Journal of Psychiatry
Attention Deficit Hyperactivity DisorderOpioid Use Disorder Treatment
Cited by 253
- Verified
Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam‐controlled randomized clinical trial
Grunebaum, M. F., Ellis, S. P., Keilp, J. G., Moitra, V. K., Cooper, T. B., Marver, J. E., Burke, A. K., Milak, M. S., Sublette, M. E., Oquendo, M. A., et al. (2017) · Bipolar Disorders
Treatment of Major DepressionBipolar Disorder and Treatment
Cited by 174
- Verified
Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects
Angrist, B., Corwin, J., Bartlik, B., & Cooper, T. (1987) · Biological Psychiatry
Neurotransmitter Receptor Influence on BehaviorAttention Deficit Hyperactivity Disorder
Cited by 171
- Verified
A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder
Milak, M. S., Proper, C. J., Mulhern, S. T., Parter, A. L., Kegeles, L. S., Ogden, R. T., Mao, X., Rodriguez, C. I., Oquendo, M. A., Suckow, R. F., et al. (2016) · Molecular Psychiatry
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 144
- Verified
Blunted HPA Axis Activity in Suicide Attempters Compared to those at High Risk for Suicidal Behavior
Melhem, N. M., Keilp, J. G., Porta, G., Oquendo, M. A., Burke, A., Stanley, B., Cooper, T. B., Mann, J. J., & Brent, D. A. (2016) · Neuropsychopharmacology
Stress Responses and CortisolSuicide and Self-Harm Studies
Cited by 143
- Verified
Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression
Parsey, R. V., Oquendo, M. A., Zea-Ponce, Y., Rodenhiser, J., Kegeles, L. S., Pratap, M., Cooper, T. B., Van Heertum, R., Mann, J. J., & Laruelle, M. (2001) · Biological Psychiatry
Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression
Cited by 133
- Verified
Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide
Abi-Dargham, A., Kegeles, L. S., Zea-Ponce, Y., Mawlawi, O., Martinez, D., Mitropoulou, V., O'Flynn, K., Koenigsberg, H. W., Van Heertum, R., Cooper, T., et al. (2004) · Biological Psychiatry
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 128
- Verified
Lower cortisol levels in depressed patients with comorbid post-traumatic stress disorder
Oquendo, M. A., Echavarria, G., Galfalvy, H. C., Grunebaum, M. F., Burke, A., Barrera, A., Cooper, T. B., Malone, K. M., & John Mann, J. (2003) · Neuropsychopharmacology
Stress Responses and CortisolPosttraumatic Stress Disorder Research
Cited by 124
- Verified
Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain
Perumal, A. S., Gopal, V. B., Tordzro, W. K., Cooper, T. B., & Cadet, J. L. (1992) · Brain Research Bulletin
Antioxidant Activity and Oxidative StressParkinson's Disease Mechanisms and Treatments
Cited by 120
- Verified
Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment
Pappadopulos, E., Jensen, P. S., Chait, A. R., Arnold, L. E., Swanson, J. M., Greenhill, L. L., Hechtman, L., Chuang, S., Wells, K. C., Pelham, W., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderMedication Adherence and Compliance
Cited by 112
- Verified
DNA Methylation Perturbations in Genes Involved in Polyunsaturated Fatty Acid Biosynthesis Associated with Depression and Suicide Risk
Haghighi, F., Galfalvy, H., Chen, S., Huang, Y.-Y., Cooper, T. B., Burke, A. K., Oquendo, M. A., Mann, J. J., & Sublette, M. E. (2015) · Frontiers in Neurology
Epigenetics and DNA MethylationFatty Acid Research and Health
Cited by 73
- Verified
Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders
Liu, J. J., Galfalvy, H. C., Cooper, T. B., Oquendo, M. A., Grunebaum, M. F., Mann, J. J., & Sublette, M. E. (2013) · The Journal of Clinical Psychiatry
Fatty Acid Research and HealthTryptophan and brain disorders
Cited by 73
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free